Sava Technologies
PrivateLast Round
Series B
Oct 9, 2026
Est. Valuation
$32M
Total Funding Raised
$33.39M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sava Technologies is a healthtech company developing a wearable biosensor platform for real-time, multi-molecule health monitoring, with its first product being a continuous glucose monitor (CGM).
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Patient Engagement, EHR & EMR
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sava Technologies Comparables
Compare Sava Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Teladoc Health, Inc. | 71% | |
| Lark Health | 70% | |
| Abbott Laboratories | 64% |
Sava Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 9, 2026 | ||||
| Series A | Jul 31, 2025 | ||||
| Seed | Jun 21, 2024 | ||||
| Seed | Jun 1, 2020 | ||||
| Grant | Sep 1, 2019 |
Key People
Founding team and executive leadership
Sava Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| True | Series A |
| Simplyhealth Ventures | Series B |
| Solo Investments | Series A |
| Athletico Ventures | Series A |
| Solo Investments Holdings | Series A |
| Koinos Capital SGR | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 9, 2026
$36M round led by Ascensia Diabetes Care.
- Jul 25, 2026
Monthly visitors increased 35% MoM, reaching 7.3K.
Recent news
Latest coverage and updates
- is_developingOct 13, 2026
Sava Technologies Ltd. is developing a wearable that continuously tracks glucose and additional biomarkers, plans to start a key trial in 2026, and has an exclusive sales partnership with Ascensia.
- receives_financingOct 9, 2026
On Oct 9th '26, Sava Technologies Ltd. receives a $36M Series B led by Ascensia Diabetes Care, with participation from Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, and Pentland Ventures, to accelerate manufacturing scale-up ahead of a pivotal clinical study in United Kingdom.
Sava Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sava Technologies's valuation, stock price, and market status.
Is Sava Technologies a public or private company?
Sava Technologies is a private company.
What is the current stock price of Sava Technologies?
Sava Technologies is a private company, so its shares have no public market price. Caplight tracks Sava Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sava Technologies worth (valuation)?
Sava Technologies's valuation is estimated at $32.0M based on funding round data.
Can I buy Sava Technologies stock?
Sava Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sava Technologies's last funding round?
Sava Technologies's most recent funding round was Series B on October 9, 2026.
Who are the main investors in Sava Technologies?
Key investors in Sava Technologies include Pentland Ventures, Balderton Capital, Exor Ventures.
Will Sava Technologies IPO soon?
No public IPO plans have been announced for Sava Technologies.
How can I track Sava Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Sava Technologies's shares on secondary markets.